Introduction: Human genes responsible for human antigen presentation and transplant rejection functions are located on the short arm of Chromosome 6, and are called the Major Histocompatibility Complex (MHC). Moreover, the primary physiologic function of MHC molecules is to present peptides to T lymphocytes. MHC molecules are integral components of the ligands that most T cells recognize, since the T cell receptor (TCR) has specificity for complexes of foreign antigenic peptides, as well as self-MHC molecules. Aim: Our investigation attempts to investigate the presence of HLA-DPDQDR within lesional skin biopsies from patients affected by autoimmune skin blistering diseases (ABDs).
Introduction
The Major Histocompatibility Complex (MHC) is central to the adaptive immune response [1] . One of the most polymorphic genetic systems, the Human Leukocyte Antigen (HLA) system is divided into Class I (HLA-A, B and C) and Class II (HLA-DP, DQ and DR) molecules [1] [2] [3] . HLA-DP, DQ, and DR represent three differing isotypes, each being highly polymorphic [1] [2] [3] . Different HLA-DP variants can be protective, or alternatively, risk factors for infectious diseases, immune dysfunction, and autoimmunity [1] [2] [3] . Few studies have investigated the presence of HLA Class II in lesional skin from patients affected by ABDs [4] [5] [6] .
Our present investigation attempted to study the presence of HLA-DP, DQ, and DR in multiple ABDs by performing immunohistochemistry (IHC) stains on lesional skin biopsies.
Material and Methods

Subjects of study
We tested 30 biopsies from patients affected by EPF in El Bagre, Colombia, South America (El Bagre-EPF) and 15 normal controls from the endemic area [3] [4] [5] . We also utilized 15 control skin biopsies from plastic surgery reduction patients in the USA, taken from the chest and/or abdomen. We also studied 15 biopsies from healthy controls from the USA. We tested archival biopsies from patients with selected ABDs, including 30 patients with bullous pemphigoid (BP), 20 with pemphigus vulgaris (PV), 8 with pemphigus foliaceus (PF), 14 with dermatitis herpetiformis (DH) and 2 with epidermolysis bullosa acquisita (EBA). Biopsies were fixed in 10% buffered formalin, then embedded in paraffin and cut at 4 micron thicknesses. The tissue was then submitted for hematoxylin and eosin (H&E) and IHC staining, performed as previously described [7] [8] [9] [10] [11] . In addition, we also tested biopsies from the archival files of two private, board certified dermatopathology laboratories in the USA; these patients underwent primary diagnostic biopsies, and were not taking immunosuppressive therapeutic medications at the time of biopsy. We evaluated 20 biopsies from bullous pemphigoid (BP) patients, 20 from patients with pemphigus vulgaris (PV), 8 patient biopsies with pemphigus foliaceus (PF), 12 from patients with dermatitis herpetiformis (DH) and 3 from epidermolysis bullosa acquisita. For all of the El Bagre area patients and controls, we obtained written consent, as well as Institutional Review Board permission from the local hospital. The archival biopsies were IRB exempt due to the lack of patient identifiers. In both dermatopathology laboratories, each biopsy also was sent for direct immunofluorescence performed as previous described [7] [8] [9] [10] [11] , for correlation with the H&E diagnoses.
IHC staining
The staining of the antibodies was evaluated utilizing hematoxylin-counterstained histologic sections. IHC staining was performed as previously described [7] [8] [9] [10] [11] . For IHC, we utilized a Dako monoclonal mouse anti-human HLA-DP, DQ, and DR Clone CR3/43 antibody.
Statistical analysis
For statistical analysis, the non-parametric Mann-Whitney U-test was used to calculate significant levels for all measurements. Values of p<0.05 were considered statistically significant.
Results
Among patients with El Bagre EPF, 23/30 exhibited positive staining in the upper dermal blood vessels and perivascular inflammatory infiltrates with a significance of p<0.05. Also, positivity was seen around the neurovascular supply structures of sebaceous glands, and around dermal blood vessels surrounding eccrine ducts ( Fig. 1 -3 ). Only two controls from the endemic area displayed positive staining, specifically in some upper dermal perivascular infiltrates (p<0.05); controls from the USA stained uniformly negative (p<0.05). Among BP patients, 18/20 stained positive for HLA-DP, DQ and DR in neurovascular packages around dermal eccrine gland ducts. Positivity was also noted under subepidermal blisters, along the bases of the blisters and within dermal endothelial/mesenchymal cell junction-like structures, especially in the middle dermis (p<0.05). In PV patients, 14/20 stained positive within upper dermal perivascular infiltrates, above intraepidermal blisters and around dermal eccrine gland ducts (p<0.05) (Figs. 1  -3 ). In patient biopsies with PF, 6/8 stained positive within the epidermal stratum granulosum, and around neurovascular packages around eccrine ducts. Among patients with DH, 9/12 exhibited positive staining, primarily under subepidermal blisters, as well as in superficial dermal perivascular infiltrates (p<0.05). The 3 cases of EBA stained positive around blood vessels in the middle and upper dermis, with some staining in eccrine sweat glands and in the areas of inflammation below the blisters (Fig. 1 -3) . Figure 1 documents the most common patterns of HLA-DP, DQ, and DR staining positivity found in the patients with ABDs. Please also notice focal cells with positive staining in the epidermis of most of the ABDs. e. An EBA case, with positive staining on epidermal cells above the blister (brown staining; red arrow) and also around dermal blood vessels (brown staining; black arrows). f. A BP case, with generally linear staining under the blister along the basement membrane zone (brown staining; brown arrow), and around dermal blood vessels. Please also note positive staining on some cells in the epidermis.
Discussion
Several previous studies, often utilizing serum, have addressed the HLA haplotype distribution utilizing ABD cases and controls [5, 6, [12] [13] [14] [15] . These studies concluded that some HLA alleles strongly predispose toward and/or protect against ABDs. Antibodies against HLA-DPDQDR principally label B lymphocytes, lymph node interdigitating reticulum cells, Langerhans cells and non-Langerhans macrophages. The specific antibody we utilized is known to react with the alpha and beta-chains of all products of the DP, DQ and DR subregions. Our study is one of the few demonstrating the presence of cells carrying appropriate molecules to react in situ with this antibody to multiple HLA Class II antigens. Our study also demonstrates that antigen recognition, and possibly also the active immune response, does not only occur solely in blister areas in pemphigus and/or pemphigoids, as traditionally thought. These processes also likely occur in other areas where we have previously shown ABD immune reactivity and cell signaling, specifically areas staining positive for ribosomal protein S6-ps240, cyclo-oxygenase 2, proteases and protease inhibitors. These areas specifically include neurovascular supplies to multiple skin appendageal structures, eccrine gland coils and ducts, and mesenchymal/endothelial cell junction-like structures in the dermis [16] [17] [18] [19] [20] [21] .
